These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 27756965)

  • 1. Torsades de pointes induced by concomitant use of chlorpheniramine and propranolol: An unusual presentation with no QT prolongation.
    Ösken A; Yelgeç NS; Zehir R; Öz TK; Yaylacı S; Akdemir R; Gündüz H
    Indian J Pharmacol; 2016; 48(4):462-465. PubMed ID: 27756965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QT prolongation, torsades des pointes, and cardiac arrest after 4 mg of IV ondansetron.
    Orozco BS; Lee SC; Fuchs RT; Fushianes GD; Cole JB
    Am J Emerg Med; 2023 Jun; 68():214.e3-214.e6. PubMed ID: 37085406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced torsades de pointes in one patient with congenital long QT syndrome.
    Hsieh MH; Chen SA; Chiang CE; Tai CT; Lee SH; Wen ZC; Chang MS
    Int J Cardiol; 1996 Apr; 54(1):85-8. PubMed ID: 8792191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torsades de pointes tachycardia induced by common cold compound medication containing chlorpheniramine.
    Nia AM; Fuhr U; Gassanov N; Erdmann E; Er F
    Eur J Clin Pharmacol; 2010 Nov; 66(11):1173-5. PubMed ID: 20676621
    [No Abstract]   [Full Text] [Related]  

  • 5. QTc prolongation and torsades de pointes due to a coadministration of fluoxetine and amiodarone in a patient with implantable cardioverter-defibrillator: Case report and review of the literature.
    Wei A; Peng J; Gu Z; Li J
    Medicine (Baltimore); 2017 Dec; 96(49):e9071. PubMed ID: 29245320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acquired long QT syndrome and cardiac arrest after general anesthesia. Case report and review of literature].
    Leclercq T; Parrel S; Mierdl S; Cottin Y; Girard C
    Ann Fr Anesth Reanim; 2014 Jun; 33(6):421-6. PubMed ID: 24880555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methadone-induced torsade de pointes in a patient with normal baseline QT interval.
    Almehmi A; Malas AM; Yousufuddin M; Rosencrance JG
    W V Med J; 2004; 100(4):147-8. PubMed ID: 15471174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The perfect storm: Torsades de Pointes in a child with leukemia.
    Bagatell R; Hainstock M; Lowe MC; Barber BJ; Samson RA
    Pediatr Blood Cancer; 2007 Dec; 49(7):996-9. PubMed ID: 16333840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dobutamine infusion for unmasking long QT syndrome and torsades de pointes.
    Quan F; Peng G; Kangan C; Dayi H; Cuilan L; Richard CC
    Clin Cardiol; 2009 Jun; 32(6):E79-82. PubMed ID: 19353679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QT interval prolongation and torsades de pointes due to erythromycin lactobionate.
    Oberg KC; Bauman JL
    Pharmacotherapy; 1995; 15(6):687-92. PubMed ID: 8602374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciprofloxacin-induced acquired long QT syndrome.
    Prabhakar M; Krahn AD
    Heart Rhythm; 2004 Nov; 1(5):624-6. PubMed ID: 15851230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
    Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C
    Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QTc prolongation, torsades de pointes, and psychotropic medications.
    Beach SR; Celano CM; Noseworthy PA; Januzzi JL; Huffman JC
    Psychosomatics; 2013; 54(1):1-13. PubMed ID: 23295003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moxifloxacin-induced torsades de pointes.
    Sherazi S; DiSalle M; Daubert JP; Shah AH
    Cardiol J; 2008; 15(1):71-3. PubMed ID: 18651388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone and torsade de pointes: case report and review of the literature.
    Iskandar SB; Abi-Saleh BS; Mechleb BK; Fahrig SA
    Tenn Med; 2007 Feb; 100(2):35-7, 42. PubMed ID: 17378505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clarithromycin-Induced Torsades de Pointes.
    Chang NL; Shah P; Bikkina M; Shamoon F
    Am J Ther; 2016; 23(3):e955-6. PubMed ID: 25057773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QT interval prolongation and torsades de pointes in a patient undergoing treatment with vorinostat: a case report and review of the literature.
    Lynch DR; Washam JB; Newby LK
    Cardiol J; 2012; 19(4):434-8. PubMed ID: 22825908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac arrest and electrical storm due to recurrent torsades de pointes caused by concomitant clarithromycin, cotrimoxazole and amiodarone treatment.
    Bienias P; Ciurzyński M; Paczyńska M; Pruszczyk P
    Pol Merkur Lekarski; 2014 Nov; 37(221):285-8. PubMed ID: 25546990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythromycin induced Torsades de Pointes: case report and review of the literature.
    Rezkalla MA; Pochop C
    S D J Med; 1994 May; 47(5):161-4. PubMed ID: 8047870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.